ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Organ Transplant Rejection Medicine Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-6Q10594
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Organ Transplant Rejection Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Global Organ Transplant Rejection Medicine Market Research Report 2025

Code: QYRE-Auto-6Q10594
Report
March 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Novartis
F Hoffmann La Roche Ltd
Astellas Pharma Inc
Pfizer Inc
AbbVie
Allergan plc
Bristol Myers Squibb Company
Sanofi

Organ Transplant Rejection Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Organ Transplant Rejection Medicine Market

Organ Transplant Rejection Medicine Market

The global market for Organ Transplant Rejection Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Organ Transplant Rejection Medicine have enhanced short-term graft survival and minimized the rate of acute organ transplant rejection.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Organ Transplant Rejection Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Rejection Medicine.
The Organ Transplant Rejection Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Organ Transplant Rejection Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ Transplant Rejection Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Organ Transplant Rejection Medicine Market Report

Report Metric Details
Report Name Organ Transplant Rejection Medicine Market
CAGR 5%
Segment by Type
Segment by Application
  • Kidney Transplant
  • Bone Marrow Transplant
  • Liver Transplant
  • Heart Transplant
  • Lung Transplant
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., Astellas Pharma, Inc., Pfizer, Inc., AbbVie, Inc., Allergan plc., Bristol-Myers Squibb Company, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Organ Transplant Rejection Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Organ Transplant Rejection Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Organ Transplant Rejection Medicine Market report?

Ans: The main players in the Organ Transplant Rejection Medicine Market are GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., Astellas Pharma, Inc., Pfizer, Inc., AbbVie, Inc., Allergan plc., Bristol-Myers Squibb Company, Sanofi

What are the Application segmentation covered in the Organ Transplant Rejection Medicine Market report?

Ans: The Applications covered in the Organ Transplant Rejection Medicine Market report are Kidney Transplant, Bone Marrow Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Others

What are the Type segmentation covered in the Organ Transplant Rejection Medicine Market report?

Ans: The Types covered in the Organ Transplant Rejection Medicine Market report are Steroids, Antibodies, mTOR Inhibitors, Antiproliferative Agents, Calcineurin Inhibitors

Recommended Reports

Transplantation & Immunology

Pharmaceutical Markets

Chronic & Specialty Disease

1 Organ Transplant Rejection Medicine Market Overview
1.1 Product Definition
1.2 Organ Transplant Rejection Medicine by Type
1.2.1 Global Organ Transplant Rejection Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Steroids
1.2.3 Antibodies
1.2.4 mTOR Inhibitors
1.2.5 Antiproliferative Agents
1.2.6 Calcineurin Inhibitors
1.3 Organ Transplant Rejection Medicine by Application
1.3.1 Global Organ Transplant Rejection Medicine Market Value by Application (2024 VS 2031)
1.3.2 Kidney Transplant
1.3.3 Bone Marrow Transplant
1.3.4 Liver Transplant
1.3.5 Heart Transplant
1.3.6 Lung Transplant
1.3.7 Others
1.4 Global Organ Transplant Rejection Medicine Market Size Estimates and Forecasts
1.4.1 Global Organ Transplant Rejection Medicine Revenue 2020-2031
1.4.2 Global Organ Transplant Rejection Medicine Sales 2020-2031
1.4.3 Global Organ Transplant Rejection Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Organ Transplant Rejection Medicine Market Competition by Manufacturers
2.1 Global Organ Transplant Rejection Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Organ Transplant Rejection Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Organ Transplant Rejection Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Organ Transplant Rejection Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Organ Transplant Rejection Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Organ Transplant Rejection Medicine, Product Type & Application
2.7 Global Key Manufacturers of Organ Transplant Rejection Medicine, Date of Enter into This Industry
2.8 Global Organ Transplant Rejection Medicine Market Competitive Situation and Trends
2.8.1 Global Organ Transplant Rejection Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Organ Transplant Rejection Medicine Players Market Share by Revenue
2.8.3 Global Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Organ Transplant Rejection Medicine Market Scenario by Region
3.1 Global Organ Transplant Rejection Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Organ Transplant Rejection Medicine Sales by Region: 2020-2031
3.2.1 Global Organ Transplant Rejection Medicine Sales by Region: 2020-2025
3.2.2 Global Organ Transplant Rejection Medicine Sales by Region: 2026-2031
3.3 Global Organ Transplant Rejection Medicine Revenue by Region: 2020-2031
3.3.1 Global Organ Transplant Rejection Medicine Revenue by Region: 2020-2025
3.3.2 Global Organ Transplant Rejection Medicine Revenue by Region: 2026-2031
3.4 North America Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.4.1 North America Organ Transplant Rejection Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Organ Transplant Rejection Medicine Sales by Country (2020-2031)
3.4.3 North America Organ Transplant Rejection Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.5.1 Europe Organ Transplant Rejection Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Organ Transplant Rejection Medicine Sales by Country (2020-2031)
3.5.3 Europe Organ Transplant Rejection Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Organ Transplant Rejection Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Organ Transplant Rejection Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.7.1 Latin America Organ Transplant Rejection Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Organ Transplant Rejection Medicine Sales by Country (2020-2031)
3.7.3 Latin America Organ Transplant Rejection Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Organ Transplant Rejection Medicine Sales by Type (2020-2031)
4.1.1 Global Organ Transplant Rejection Medicine Sales by Type (2020-2025)
4.1.2 Global Organ Transplant Rejection Medicine Sales by Type (2026-2031)
4.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Type (2020-2031)
4.2 Global Organ Transplant Rejection Medicine Revenue by Type (2020-2031)
4.2.1 Global Organ Transplant Rejection Medicine Revenue by Type (2020-2025)
4.2.2 Global Organ Transplant Rejection Medicine Revenue by Type (2026-2031)
4.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Organ Transplant Rejection Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Organ Transplant Rejection Medicine Sales by Application (2020-2031)
5.1.1 Global Organ Transplant Rejection Medicine Sales by Application (2020-2025)
5.1.2 Global Organ Transplant Rejection Medicine Sales by Application (2026-2031)
5.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Application (2020-2031)
5.2 Global Organ Transplant Rejection Medicine Revenue by Application (2020-2031)
5.2.1 Global Organ Transplant Rejection Medicine Revenue by Application (2020-2025)
5.2.2 Global Organ Transplant Rejection Medicine Revenue by Application (2026-2031)
5.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Organ Transplant Rejection Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline plc
6.1.1 GlaxoSmithKline plc Company Information
6.1.2 GlaxoSmithKline plc Description and Business Overview
6.1.3 GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline plc Organ Transplant Rejection Medicine Product Portfolio
6.1.5 GlaxoSmithKline plc Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Company Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis AG Organ Transplant Rejection Medicine Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 F. Hoffmann-La Roche Ltd. Company Information
6.3.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.3.3 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product Portfolio
6.3.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.4 Astellas Pharma, Inc.
6.4.1 Astellas Pharma, Inc. Company Information
6.4.2 Astellas Pharma, Inc. Description and Business Overview
6.4.3 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product Portfolio
6.4.5 Astellas Pharma, Inc. Recent Developments/Updates
6.5 Pfizer, Inc.
6.5.1 Pfizer, Inc. Company Information
6.5.2 Pfizer, Inc. Description and Business Overview
6.5.3 Pfizer, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer, Inc. Organ Transplant Rejection Medicine Product Portfolio
6.5.5 Pfizer, Inc. Recent Developments/Updates
6.6 AbbVie, Inc.
6.6.1 AbbVie, Inc. Company Information
6.6.2 AbbVie, Inc. Description and Business Overview
6.6.3 AbbVie, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AbbVie, Inc. Organ Transplant Rejection Medicine Product Portfolio
6.6.5 AbbVie, Inc. Recent Developments/Updates
6.7 Allergan plc.
6.7.1 Allergan plc. Company Information
6.7.2 Allergan plc. Description and Business Overview
6.7.3 Allergan plc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Allergan plc. Organ Transplant Rejection Medicine Product Portfolio
6.7.5 Allergan plc. Recent Developments/Updates
6.8 Bristol-Myers Squibb Company
6.8.1 Bristol-Myers Squibb Company Company Information
6.8.2 Bristol-Myers Squibb Company Description and Business Overview
6.8.3 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product Portfolio
6.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Organ Transplant Rejection Medicine Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Organ Transplant Rejection Medicine Industry Chain Analysis
7.2 Organ Transplant Rejection Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Organ Transplant Rejection Medicine Production Mode & Process Analysis
7.4 Organ Transplant Rejection Medicine Sales and Marketing
7.4.1 Organ Transplant Rejection Medicine Sales Channels
7.4.2 Organ Transplant Rejection Medicine Distributors
7.5 Organ Transplant Rejection Medicine Customer Analysis
8 Organ Transplant Rejection Medicine Market Dynamics
8.1 Organ Transplant Rejection Medicine Industry Trends
8.2 Organ Transplant Rejection Medicine Market Drivers
8.3 Organ Transplant Rejection Medicine Market Challenges
8.4 Organ Transplant Rejection Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Novartis
F Hoffmann La Roche Ltd
Astellas Pharma Inc
Pfizer Inc
AbbVie
Allergan plc
Bristol Myers Squibb Company
Sanofi
List of Tables
 Table 1. Global Organ Transplant Rejection Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Organ Transplant Rejection Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Organ Transplant Rejection Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Organ Transplant Rejection Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Organ Transplant Rejection Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Organ Transplant Rejection Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Organ Transplant Rejection Medicine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Organ Transplant Rejection Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Organ Transplant Rejection Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Organ Transplant Rejection Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Organ Transplant Rejection Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Organ Transplant Rejection Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Rejection Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Organ Transplant Rejection Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Organ Transplant Rejection Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Organ Transplant Rejection Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Organ Transplant Rejection Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Organ Transplant Rejection Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Organ Transplant Rejection Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Organ Transplant Rejection Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Organ Transplant Rejection Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Organ Transplant Rejection Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Organ Transplant Rejection Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Organ Transplant Rejection Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Organ Transplant Rejection Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Organ Transplant Rejection Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Organ Transplant Rejection Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Organ Transplant Rejection Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Organ Transplant Rejection Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Organ Transplant Rejection Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Organ Transplant Rejection Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Organ Transplant Rejection Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Organ Transplant Rejection Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Organ Transplant Rejection Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Organ Transplant Rejection Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Organ Transplant Rejection Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Organ Transplant Rejection Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Organ Transplant Rejection Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Organ Transplant Rejection Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Organ Transplant Rejection Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Organ Transplant Rejection Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Organ Transplant Rejection Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Organ Transplant Rejection Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline plc Company Information
 Table 71. GlaxoSmithKline plc Description and Business Overview
 Table 72. GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline plc Organ Transplant Rejection Medicine Product
 Table 74. GlaxoSmithKline plc Recent Developments/Updates
 Table 75. Novartis AG Company Information
 Table 76. Novartis AG Description and Business Overview
 Table 77. Novartis AG Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis AG Organ Transplant Rejection Medicine Product
 Table 79. Novartis AG Recent Developments/Updates
 Table 80. F. Hoffmann-La Roche Ltd. Company Information
 Table 81. F. Hoffmann-La Roche Ltd. Description and Business Overview
 Table 82. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product
 Table 84. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 85. Astellas Pharma, Inc. Company Information
 Table 86. Astellas Pharma, Inc. Description and Business Overview
 Table 87. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product
 Table 89. Astellas Pharma, Inc. Recent Developments/Updates
 Table 90. Pfizer, Inc. Company Information
 Table 91. Pfizer, Inc. Description and Business Overview
 Table 92. Pfizer, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer, Inc. Organ Transplant Rejection Medicine Product
 Table 94. Pfizer, Inc. Recent Developments/Updates
 Table 95. AbbVie, Inc. Company Information
 Table 96. AbbVie, Inc. Description and Business Overview
 Table 97. AbbVie, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. AbbVie, Inc. Organ Transplant Rejection Medicine Product
 Table 99. AbbVie, Inc. Recent Developments/Updates
 Table 100. Allergan plc. Company Information
 Table 101. Allergan plc. Description and Business Overview
 Table 102. Allergan plc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Allergan plc. Organ Transplant Rejection Medicine Product
 Table 104. Allergan plc. Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Company Information
 Table 106. Bristol-Myers Squibb Company Description and Business Overview
 Table 107. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product
 Table 109. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 110. Sanofi Company Information
 Table 111. Sanofi Description and Business Overview
 Table 112. Sanofi Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Organ Transplant Rejection Medicine Product
 Table 114. Sanofi Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Organ Transplant Rejection Medicine Distributors List
 Table 118. Organ Transplant Rejection Medicine Customers List
 Table 119. Organ Transplant Rejection Medicine Market Trends
 Table 120. Organ Transplant Rejection Medicine Market Drivers
 Table 121. Organ Transplant Rejection Medicine Market Challenges
 Table 122. Organ Transplant Rejection Medicine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Organ Transplant Rejection Medicine
 Figure 2. Global Organ Transplant Rejection Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Organ Transplant Rejection Medicine Market Share by Type: 2024 & 2031
 Figure 4. Steroids Product Picture
 Figure 5. Antibodies Product Picture
 Figure 6. mTOR Inhibitors Product Picture
 Figure 7. Antiproliferative Agents Product Picture
 Figure 8. Calcineurin Inhibitors Product Picture
 Figure 9. Global Organ Transplant Rejection Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Organ Transplant Rejection Medicine Market Share by Application: 2024 & 2031
 Figure 11. Kidney Transplant
 Figure 12. Bone Marrow Transplant
 Figure 13. Liver Transplant
 Figure 14. Heart Transplant
 Figure 15. Lung Transplant
 Figure 16. Others
 Figure 17. Global Organ Transplant Rejection Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Organ Transplant Rejection Medicine Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Organ Transplant Rejection Medicine Sales (2020-2031) & (K Units)
 Figure 20. Global Organ Transplant Rejection Medicine Average Price (USD/Unit) & (2020-2031)
 Figure 21. Organ Transplant Rejection Medicine Report Years Considered
 Figure 22. Organ Transplant Rejection Medicine Sales Share by Manufacturers in 2024
 Figure 23. Global Organ Transplant Rejection Medicine Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Organ Transplant Rejection Medicine Players: Market Share by Revenue in Organ Transplant Rejection Medicine in 2024
 Figure 25. Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Organ Transplant Rejection Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Organ Transplant Rejection Medicine Sales Market Share by Country (2020-2031)
 Figure 28. North America Organ Transplant Rejection Medicine Revenue Market Share by Country (2020-2031)
 Figure 29. United States Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Organ Transplant Rejection Medicine Sales Market Share by Country (2020-2031)
 Figure 32. Europe Organ Transplant Rejection Medicine Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Organ Transplant Rejection Medicine Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Organ Transplant Rejection Medicine Revenue Market Share by Region (2020-2031)
 Figure 40. China Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. China Taiwan Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Organ Transplant Rejection Medicine Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Organ Transplant Rejection Medicine Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Organ Transplant Rejection Medicine Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Organ Transplant Rejection Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Organ Transplant Rejection Medicine by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Organ Transplant Rejection Medicine by Type (2020-2031)
 Figure 61. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Organ Transplant Rejection Medicine by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Organ Transplant Rejection Medicine by Application (2020-2031)
 Figure 64. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Application (2020-2031)
 Figure 65. Organ Transplant Rejection Medicine Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Organ Transplant Anti rejection Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heart Transplant Rejection Treatment Market Research Report 2025
Global Kidney Transplant Rejection Therapeutics Market Research Report 2024
Global Kidney Transplant Anti Rejection Drugs Market Research Report 2024
Organ Transplant Rejection Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Solid Organ Transplantation Rejection SOT Market Research Report 2024
Global Transplantation Therapeutics Drugs Market Research Report 2024
Global Solid Organ Transplant Immunosuppressant Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Organ Transplant Immunosuppressant Drugs Market Insights Forecast to 2030
Transplant Drug Concentration Monitoring Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Organ Rejection Prophylaxis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Organ Preservation Technology Market Research Report 2025
Global Lung Transplant Market Research Report 2024
Global Drug for Organ Rejection Prophylaxis Market Research Report 2025
Global Liver Transplant Anti Rejection Drugs Market Research Report 2024
Global Cyclosporine Drugs Market Research Report 2025
Global Organ Preservation Device Market Research Report 2024
Global Organ Preservation and Perfusion Solution Market Research Report 2025
Global Kidney Medicine Market Insights Forecast to 2030
Global Organ and Tissue Transplantation and Alternative Market Research Report 2024

RELATED REPORTS

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global ENT Surgery Navigation Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11O6178
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Robotics in Laparoscopic Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7R6277
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Bone Allografts Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9I8785
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions